CUTANEOUS MELANOMA, STAGE III
Clinical trials for CUTANEOUS MELANOMA, STAGE III explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS MELANOMA, STAGE III trials appear
Sign up with your email to follow new studies for CUTANEOUS MELANOMA, STAGE III, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Less surgery may be just as effective for advanced melanoma after immunotherapy
Disease control Recruiting nowThis study tests whether removing only the largest affected lymph node (index node) is as good as removing all lymph nodes in the area for stage III melanoma. After 6 weeks of standard immunotherapy, 1500 participants will be randomly assigned to one of the two surgeries. The goa…
Matched conditions: CUTANEOUS MELANOMA, STAGE III
Phase: NA • Sponsor: Melanoma Institute Australia • Aim: Disease control
Last updated May 26, 2026 03:54 UTC
-
New Shot-in-Tumor combo aims to shrink melanoma before surgery
Disease control Recruiting nowThis study tests whether injecting two immunotherapy drugs (ipilimumab and nivolumab) directly into melanoma tumors before surgery can destroy more cancer cells and cause fewer side effects than standard treatment. About 50 adults with stage III melanoma that can be surgically re…
Matched conditions: CUTANEOUS MELANOMA, STAGE III
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated May 26, 2026 03:52 UTC
-
New study aims to decode immunotherapy side effects in melanoma patients
Knowledge-focused Recruiting nowThis study follows 300 adults with stage IIB to IV melanoma who are receiving immune checkpoint inhibitors. Researchers will track 53 different symptoms over time to identify which are most common, severe, and distressing. The goal is to find risk factors linked to worse symptoms…
Matched conditions: CUTANEOUS MELANOMA, STAGE III
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC